Cargando…
Pseudomonas mendocina Urinary Tract Infection: A Case Report and Literature Review
Pseudomonas mendocina is a Gram-negative bacillus from the family Pseudomonadaceae. The first P. mendocina-related infection was reported in 1992. Although a rare cause of infections, P. mendocina has been known to cause severe infections that require intensive treatment. We present the first docume...
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Cureus
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9045790/ https://www.ncbi.nlm.nih.gov/pubmed/35495004 http://dx.doi.org/10.7759/cureus.23583 |
_version_ | 1784695391969607680 |
---|---|
author | Vo, Thy Maisuradze, Nodari Maglakelidze, David Kalra, Tanisha McFarlane, Isabel M |
author_facet | Vo, Thy Maisuradze, Nodari Maglakelidze, David Kalra, Tanisha McFarlane, Isabel M |
author_sort | Vo, Thy |
collection | PubMed |
description | Pseudomonas mendocina is a Gram-negative bacillus from the family Pseudomonadaceae. The first P. mendocina-related infection was reported in 1992. Although a rare cause of infections, P. mendocina has been known to cause severe infections that require intensive treatment. We present the first documented case of urinary tract infection caused by P. mendocina. An 83-year-old male with a past medical history of diabetes, hypertension, coronary artery disease, and prostate cancer with bone metastases, currently being treated with abiraterone and prednisone, presented with subjective fever, fatigue, altered mental status, dysuria, and hematuria of one-week duration. He was found to have a complicated urinary tract infection with an incidental asymptomatic COVID-19 infection on admission. The patient was empirically treated with ceftriaxone and switched to cefepime for broader coverage on day two of hospitalization. Urine culture reported the presence of P. mendocina with resistance only to fluoroquinolones. Ceftriaxone was reinstated. The patient was successfully treated with a seven-day course of ceftriaxone (days 1-3, days 6-7) and cefepime (days 4-5) but continued to remain inpatient for a later symptomatic COVID-19 pneumonia with discharge on day 15. The majority of P. mendocina infections present as skin and soft tissue infections, infective endocarditis, meningitis, and bacteremia. Ours is the first documented case of urinary tract infection caused by P. mendocina, particularly in an immunocompromised COVID-19 patient, and the second to report P. mendocina with resistance to fluoroquinolones. This report contributes to the growing literature regarding P. mendocina-related infections. |
format | Online Article Text |
id | pubmed-9045790 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Cureus |
record_format | MEDLINE/PubMed |
spelling | pubmed-90457902022-04-28 Pseudomonas mendocina Urinary Tract Infection: A Case Report and Literature Review Vo, Thy Maisuradze, Nodari Maglakelidze, David Kalra, Tanisha McFarlane, Isabel M Cureus Internal Medicine Pseudomonas mendocina is a Gram-negative bacillus from the family Pseudomonadaceae. The first P. mendocina-related infection was reported in 1992. Although a rare cause of infections, P. mendocina has been known to cause severe infections that require intensive treatment. We present the first documented case of urinary tract infection caused by P. mendocina. An 83-year-old male with a past medical history of diabetes, hypertension, coronary artery disease, and prostate cancer with bone metastases, currently being treated with abiraterone and prednisone, presented with subjective fever, fatigue, altered mental status, dysuria, and hematuria of one-week duration. He was found to have a complicated urinary tract infection with an incidental asymptomatic COVID-19 infection on admission. The patient was empirically treated with ceftriaxone and switched to cefepime for broader coverage on day two of hospitalization. Urine culture reported the presence of P. mendocina with resistance only to fluoroquinolones. Ceftriaxone was reinstated. The patient was successfully treated with a seven-day course of ceftriaxone (days 1-3, days 6-7) and cefepime (days 4-5) but continued to remain inpatient for a later symptomatic COVID-19 pneumonia with discharge on day 15. The majority of P. mendocina infections present as skin and soft tissue infections, infective endocarditis, meningitis, and bacteremia. Ours is the first documented case of urinary tract infection caused by P. mendocina, particularly in an immunocompromised COVID-19 patient, and the second to report P. mendocina with resistance to fluoroquinolones. This report contributes to the growing literature regarding P. mendocina-related infections. Cureus 2022-03-28 /pmc/articles/PMC9045790/ /pubmed/35495004 http://dx.doi.org/10.7759/cureus.23583 Text en Copyright © 2022, Vo et al. https://creativecommons.org/licenses/by/3.0/This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. |
spellingShingle | Internal Medicine Vo, Thy Maisuradze, Nodari Maglakelidze, David Kalra, Tanisha McFarlane, Isabel M Pseudomonas mendocina Urinary Tract Infection: A Case Report and Literature Review |
title | Pseudomonas mendocina Urinary Tract Infection: A Case Report and Literature Review |
title_full | Pseudomonas mendocina Urinary Tract Infection: A Case Report and Literature Review |
title_fullStr | Pseudomonas mendocina Urinary Tract Infection: A Case Report and Literature Review |
title_full_unstemmed | Pseudomonas mendocina Urinary Tract Infection: A Case Report and Literature Review |
title_short | Pseudomonas mendocina Urinary Tract Infection: A Case Report and Literature Review |
title_sort | pseudomonas mendocina urinary tract infection: a case report and literature review |
topic | Internal Medicine |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9045790/ https://www.ncbi.nlm.nih.gov/pubmed/35495004 http://dx.doi.org/10.7759/cureus.23583 |
work_keys_str_mv | AT vothy pseudomonasmendocinaurinarytractinfectionacasereportandliteraturereview AT maisuradzenodari pseudomonasmendocinaurinarytractinfectionacasereportandliteraturereview AT maglakelidzedavid pseudomonasmendocinaurinarytractinfectionacasereportandliteraturereview AT kalratanisha pseudomonasmendocinaurinarytractinfectionacasereportandliteraturereview AT mcfarlaneisabelm pseudomonasmendocinaurinarytractinfectionacasereportandliteraturereview |